Everything you need to know about 10 TMS Myths Debunked: Separating Science from Fiction in 2026 — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Everything to know before your first consult — questions to ask, what to expect, and how to compare providers.
Transcranial magnetic stimulation has been FDA-cleared for depression since 2008, yet misconceptions still keep patients from a treatment that could help them. Here are the ten myths we hear most often — and what the evidence actually says.
Myth 1: “TMS is the same as electroshock therapy”
False. This is the most persistent myth, and the most costly. Electroconvulsive therapy (ECT) induces a controlled seizure under general anesthesia. TMS uses magnetic pulses to stimulate a specific brain region — no anesthesia, no seizure, no memory effects. You sit in a chair, awake, and drive yourself home afterward. See our full TMS vs ECT comparison.
Myth 2: “TMS causes memory loss”
False. Memory side effects belong to ECT, not TMS. Clinical trials consistently show no negative cognitive effects from TMS — some studies suggest modest improvements in concentration as depression lifts. We reviewed the data in does TMS cause memory loss?
Myth 3: “It’s experimental”
False. TMS has FDA clearance for major depressive disorder (2008), OCD (2018), smoking cessation (2020), and anxious depression (2021). It’s endorsed in major clinical guidelines and covered by Medicare and nearly every large commercial insurer when criteria are met.
Myth 4: “Insurance never covers it”
False — with a caveat. Most insurers cover TMS for treatment-resistant depression, typically after two to four failed medication trials. The paperwork is real, but approval rates are high when documentation is thorough. Our insurance appeals guide walks through the process, including what to do after a denial.
Myth 5: “TMS is painful”
Mostly false. The sensation is a firm tapping on the scalp. The first few sessions can be uncomfortable — scalp sensitivity is the most common complaint — but it fades within a week for most patients as they acclimate. Read what TMS actually feels like for first-hand accounts.
Myth 6: “The results don’t last”
False. Durability data is one of TMS’s strengths: roughly two-thirds of responders maintain improvement at 12 months, and maintenance or booster sessions can extend gains further. Details in how long does TMS last?
Myth 7: “You have to stop your medications”
False. Most patients continue their antidepressants during TMS. The treatments work through different mechanisms and are routinely combined — many clinicians prefer keeping medication stable so progress can be attributed accurately.
Myth 8: “TMS is only for depression”
False. Beyond depression, TMS holds FDA clearances for OCD and smoking cessation, with active research in chronic pain, PTSD, and more than a dozen other conditions.
Myth 9: “If antidepressants didn’t work, nothing will”
False — and backwards. TMS was specifically studied in patients who failed medications. The landmark trials enrolled people with treatment-resistant depression, and response rates in real-world registries run 50–70%. Medication failure is the entry criterion, not a disqualifier.
Myth 10: “All TMS clinics are the same”
False. Devices, protocols, technician experience, and physician oversight vary meaningfully between providers. Outcomes depend on accurate targeting and consistent delivery. Compare providers in our clinic directory, and learn how to read clinic reviews before you choose.
The bottom line
TMS is a well-established, evidence-based treatment with a mild side-effect profile and strong durability data. If outdated information has kept you from considering it, start with the basics in What is TMS? — then talk to a provider about whether you’re a candidate.
Have a question you don’t see here? Ask real patients and specialists in our community forum.
